Cargando…

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence

BACKGROUND: Exosomal microRNAs (miRNAs) are promising candidate biomarkers for diagnosis or prognosis for breast cancer. We investigated the prognostic role of exosomal miRNAs in serum samples derived from patients with breast cancer and compared miRNA expression between serum and tumor tissues. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sueta, Aiko, Yamamoto, Yutaka, Tomiguchi, Mai, Takeshita, Takashi, Yamamoto-Ibusuki, Mutsuko, Iwase, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642528/ https://www.ncbi.nlm.nih.gov/pubmed/29050253 http://dx.doi.org/10.18632/oncotarget.19482

Ejemplares similares

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2018)

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Fujiki, Yoshitaka, et al.
Publicado: (2018)

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer
por: Hayashi, Mitsuhiro, et al.
Publicado: (2015)

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
por: Tomiguchi, Mai, et al.
Publicado: (2016)

The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer
por: Fujiwara, Saori, et al.
Publicado: (2014)

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
por: Sueta, Aiko, et al.
Publicado: (2014)

The role of exosomal microRNAs; focus on clinical applications in breast cancer
por: Sueta, Aiko, et al.
Publicado: (2019)

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2015)

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2016)

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
por: Suyama, Koichi, et al.
Publicado: (2017)

A progressive and refractory case of breast cancer with Cowden syndrome
por: Sueta, Aiko, et al.
Publicado: (2022)

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy
por: Omoto, Yoko, et al.
Publicado: (2015)

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
por: Yamamoto, Satoko, et al.
Publicado: (2013)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
por: Shiota, Takuya, et al.
Publicado: (2016)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
por: Kosaka, Yoshimasa, et al.
Publicado: (2020)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
por: Rezano, Andri, et al.
Publicado: (2013)

High density of CD204‐positive macrophages predicts worse clinical prognosis in patients with breast cancer
por: Miyasato, Yuko, et al.
Publicado: (2017)

Exosomal MiRNAs in Pediatric Cancers
por: Galardi, Angela, et al.
Publicado: (2019)

Exosomal miRNAs in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2020)

The role of Exosomal miRNAs in cancer
por: Li, Chuanyun, et al.
Publicado: (2022)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Comparative analyses of salivary exosomal miRNAs for patients with or without lung cancer
por: Liu, Mengfeng, et al.
Publicado: (2023)

Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
por: Yang, Fengming, et al.
Publicado: (2017)

Differential predictive factors for cardiovascular events in patients with or without cancer history
por: Sueta, Daisuke, et al.
Publicado: (2019)

Emerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury
por: Feng, Jia, et al.
Publicado: (2021)

Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis
por: Yang, Yongfeng, et al.
Publicado: (2022)

Exosomal miRNAs as Biomarkers for Prostate Cancer
por: Hessvik, Nina Pettersen, et al.
Publicado: (2013)

Inflammasomes: Exosomal miRNAs loaded for action
por: Matikainen, Sampsa, et al.
Publicado: (2020)

Role of Exosomal miRNAs in Heart Failure
por: Xue, Ruicong, et al.
Publicado: (2020)

miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases
por: Catelan, Silvia, et al.
Publicado: (2022)

The roles of exosomal miRNAs and lncRNAs in lung diseases
por: Li, Yang, et al.
Publicado: (2019)

Editorial: Exosomes and exosomal miRNAs as biomarkers in infection with Mycobacterium tuberculosis
por: Alipoor, Shamila D.
Publicado: (2023)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
por: Egashira, Koichi, et al.
Publicado: (2022)

Exosomal miRNAs: Biological Properties and Therapeutic Potential
por: Hu, Guoku, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i5ik52u8qr2b41luefq6ev745j